Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Duvignaud A, Lhomme E, Onaisi R, Sitta R, Gelley A, Chastang J, Piroth L, Binquet C, Dupouy J, Makinson A, Lefèvre B, Naccache JM, Roussillon C, Landman R, Wallet C, Karcher S, Journot V, Nguyen D, Pistone T, Bouchet S, Lafon ME, Molimard M, Thiébaut R, de Lamballerie X, Joseph JP, Richert L, Saint-Lary O, Djabarouti S, Wittkop L, Anglaret X, Malvy D; Coverage Study Group; SA1-1: Members of the COVERAGE France Study Group. Sponsor (CHU Bordeaux); National Trial Coordination Unit: CIC-EC 1401/EUCLID; MEREVA; National Coordinating Pharmacy; National Coordinating Laboratories; Bordeaux; Créteil; Bordeaux Study center; Investigating physicians; Coordination; Dijon Study center; Investigating physicians; Coordination; Nancy Study center: Investigating physicians; Coordination; Toulouse Study sites; Investigating physicians; Coordination; Bastia Study center; Investigating physicians; Coordination; Montpellier Study center: Investigating physicians; Coordination; Paris Study center 1: Collège National des Généralistes Enseignants (CNGE); Investigating physicians; Coordination; Paris Study center 2; Groupe Hospitalier Paris Saint Joseph (GHPSJ); Investigating physicians; Coordination; Paris Study center 3: Institut de Médecine et d’Epidémiologie Appliquée (IMEA); Coordination; Nantes/Angers Study center; Investigating physicians; Coordination; Others contributors; Scientific Advisory Board: Voting members; Non-voting members; Data Safety Monitoring Board. Clin Microbiol Infect. 2022
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT).
Lemaitre F, Grégoire M, Monchaud C, Bouchet S, Saint-Salvi B, Polard E; SFPT Therapeutic Drug Monitoring and Treatment Personalization group (STP-PT) of the French Society of Pharmacology and Therapeutics (SFPT); French Pharmacovigilance Network (CRPV); ANRS-MIE AC-43 Clinical Pharmacology Committee, joint working group; SFPT Therapeutic Drug Monitoring and Treatment Personalization group (STP-PT) of the French Society of Pharmacology and Therapeutics (SFPT); French Pharmacovigilance Network (CRPV); ANRS-MIE AC-43 Clinical Pharmacology Committee, joint working group. Therapie. 2022